Thursday, November 5, 2015

Miracle Drug by Dr. Richard Mabry Review


About the book: 
Miracle Drug
 (Abingdon, September 2015)

Overcoming these odds will take more than a miracle drug---it will take a miracle.

The infection wasn't supposed to happen, but it did. The treatment was supposed to take care of it, but it didn't. Then Dr. Josh Pearson discovers why---his patients, including the former President of the United States, have been dosed with a different strain of the original virus, one that is universally fatal. The only chance for survival is treatment with an experimental drug, but the manufacturer might already have discarded its supply.

As if treating the President of the United States isn't stressful enough, the situation goes from bad to worse when Rachel Moore, a nurse Josh is falling in love with, falls ill. With the nation's eyes on him, Josh must pull off a miracle to save a man who holds a good deal of power and the woman who holds his heart.

Purchase a copy: http://bit.ly/1L8pNgx
About the author:
Dr. Richard Mabry is a retired physician who writes "medical suspense with heart." His novels have won multiple awards: a semifinalist for International Thriller Writers' debut novel; finalists for the Carol Award, Inspirational Reader's Choice Award, and Romantic Times' Reader's Choice Award; and both finalist and winner of the Selah Award. "Miracle Drug" is his ninth published novel. He and his wife live in Frisco, Texas.

Find Richard online: 
websiteFacebookTwitter





My Review:
What is Dr. Josh Pearson going to do? He believes that he knows of a new drug not approved yet will stop people from dying because of an infection. Now, he has a huge problem . there is only enough for one person. He has 2 patients that need the drug from him. His girlfriend, and the other person who happens to be the person who used to be president of the United States.  What is he going to do? Who will he choose to save? This is a book that is full of suspense. I give this book a 5/5. I was given this book for a review by Litfuse Publicity Group and all opinions are mine. 

No comments:

Post a Comment